IGEA

IGEA is a biomedical company and a world leader in biophysical therapies. With passion, scientific research, and innovation, we are committed to providing advanced care and actively contributing to the future of medical treatment. Electrochemotherapy (ECT) is a minimally invasive locoregional therapy using the principle of electroporation for the treatment of solid tumours.

Tumour lesions of different origins can be effectively treated with ECT. It is effective at different disease stages, is generally well tolerated and can be performed subsequently or concurrently with other treatments. In breast cancer, ECT can be used to treat cutaneous malignancies.